How to Get Losartan in Michigan

At a glance
- Drug type / angiotensin II receptor blocker (ARB), oral tablet
- Approved indications / hypertension, heart failure, diabetic nephropathy (type 2)
- Prescribers in Michigan / MD, DO, NP, PA (with collaborative agreement where required)
- Telehealth Rx / Yes, permitted under Michigan telehealth law
- Typical starting dose / 50 mg once daily; range 25 to 100 mg
- Michigan Medicaid coverage / Covered with prior authorization
- Key pre-prescribing labs / BMP (creatinine, potassium), pregnancy test if applicable
- Time from consult to first dose / 1, 3 business days for standard pharmacy fill
- Compounding (503A) / Yes, licensed 503A pharmacies may compound losartan in Michigan
- LIFE trial result / Losartan reduced stroke by 25% vs. atenolol in hypertensive patients with LVH
What Is Losartan and Why Do Michigan Physicians Prescribe It?
Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three indications: hypertension in adults and children aged 6 and older, reduction of stroke risk in hypertensive patients with left ventricular hypertrophy (LVH), and nephropathy in type 2 diabetic patients with elevated serum creatinine and proteinuria. The brand name is Cozaar (Merck), but generic tablets are widely available and dispensed at virtually every Michigan pharmacy.
The drug works by blocking the AT1 receptor, which prevents angiotensin II from constricting blood vessels and triggering aldosterone release. The result is lower blood pressure, reduced cardiac afterload, and a measurable decline in proteinuria in diabetic nephropathy patients.
The LIFE trial (N=9,193, published in The Lancet, 2002) compared losartan 50 to 100 mg to atenolol 50 to 100 mg over a mean follow-up of 4.8 years in hypertensive patients with ECG-confirmed LVH. Losartan produced a 25% relative risk reduction in the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction (P<0.001), driven largely by a 25% reduction in fatal and non-fatal stroke [1]. That single trial reshaped prescribing habits across the country and remains central to current hypertension guidelines.
The American College of Cardiology / American Heart Association 2017 hypertension guidelines state: "ARBs are recommended as first-line therapy in patients with hypertension and chronic kidney disease, diabetes mellitus, or heart failure with reduced ejection fraction." [2] That guideline language explains the consistent demand for losartan among Michigan's 2.7 million adults estimated to have hypertension, per CDC 2023 prevalence data [3].
Who Can Prescribe Losartan in Michigan?
Michigan law grants prescriptive authority for Schedule-exempt drugs like losartan to several provider types. Physicians (MD, DO) hold full independent prescriptive authority. Nurse practitioners (NPs) in Michigan prescribe under a delegation agreement with a collaborating physician. Physician assistants (PAs) also prescribe under a supervision agreement. All three provider types routinely prescribe losartan.
This matters for telehealth access. A Michigan-licensed NP at a telehealth platform can write your losartan prescription independently once the platform's collaborating physician arrangement is in place. You do not need to see an MD specifically.
Michigan's Public Health Code, Act 368 of 1978, governs prescriptive authority. The Michigan Department of Licensing and Regulatory Affairs (LARA) maintains the license verification portal at michigan.gov/lara if you need to confirm a provider's active Michigan license before your appointment [4].
Prescribers must establish a valid patient-provider relationship before issuing a controlled substance, but losartan is not a controlled substance. Telehealth platforms may initiate a losartan prescription after a synchronous video or audio visit that includes a medication history review, blood pressure documentation, and a kidney-function assessment.
Getting Losartan Through Telehealth in Michigan
Telehealth prescribing of losartan in Michigan is fully permitted. No in-person visit is required.
Michigan expanded its telehealth framework under Public Act 38 of 2020, allowing licensed Michigan providers to prescribe non-controlled medications after a real-time audiovisual or telephonic evaluation. Platforms that operate legally in Michigan must verify that at least one supervising or collaborating physician holds an active Michigan license.
Step-by-step process for a telehealth losartan prescription in Michigan:
- Choose a telehealth platform with a licensed Michigan provider. Confirm the provider's Michigan license number through LARA.
- Complete the intake form. Expect questions about current blood pressure readings, prior antihypertensive use, kidney disease history, current medications (especially potassium supplements, NSAIDs, or diuretics), and pregnancy status.
- Attend the synchronous video visit. The provider will review your history and, if appropriate, send an electronic prescription (e-Rx) to your chosen Michigan pharmacy.
- Receive a lab order if baseline labs have not been done recently. Most platforms send a LabCorp or Quest order electronically.
- Pick up your prescription at the pharmacy or request mail delivery.
The average time from completed telehealth visit to a filled 30-day supply at a Michigan retail pharmacy is one to two business days, though same-day fill is possible at major chains like CVS, Walgreens, Meijer, and Rite Aid when e-prescriptions transmit before noon.
The HealthRX clinical team uses the following access pathway to determine whether a new Michigan patient can receive losartan via telehealth on the same day as their first visit:
Same-Day Approval Criteria (HealthRX Internal Framework):
- Documented home blood pressure readings (at least two readings on two separate days) provided at intake
- Serum creatinine and potassium from a lab drawn within the past 12 months
- No pregnancy, active bilateral renal artery stenosis, or concurrent ACE-inhibitor use
- No history of angioedema with any ARB or ACE inhibitor
Patients who meet all four criteria receive the e-Rx at visit close. Patients who need baseline labs first receive a bridge counseling note and a standing lab order; the prescription is issued within 24 hours of verified normal results.
What Labs Are Required Before Starting Losartan in Michigan?
Two blood tests are standard before initiating losartan: a basic metabolic panel (BMP) and, in women of childbearing age, a urine or serum pregnancy test.
The BMP matters because losartan can raise serum potassium (hyperkalemia risk) and modestly reduce glomerular filtration rate, particularly in patients with pre-existing CKD or bilateral renal artery stenosis. The 2017 ACC/AHA hypertension guideline recommends baseline creatinine, potassium, and urinalysis before starting any RAS-blocking agent [2].
Practical thresholds Michigan prescribers use:
- Serum potassium <5.0 mEq/L is generally required before initiating therapy.
- eGFR <30 mL/min/1.73 m² warrants nephrology consultation before starting an ARB.
- A creatinine rise of more than 30% above baseline within 2 weeks of starting losartan should prompt dose hold and provider reassessment.
The FDA-approved losartan label states that serum electrolytes and renal function should be monitored periodically during therapy, with particular attention in patients receiving concomitant diuretics or those with CKD [5]. After the first month on losartan, a repeat BMP is considered standard practice. Annual BMP monitoring continues for the duration of treatment.
Patients obtaining a telehealth prescription can use any CLIA-certified lab in Michigan. LabCorp and Quest both maintain numerous patient service centers across Metro Detroit, Grand Rapids, Lansing, Flint, and Ann Arbor. Results are typically available within 24 hours and can be shared with the telehealth provider through a patient portal upload or direct lab interface.
Transferring an Existing Losartan Prescription to Michigan
Moving to Michigan or visiting long-term? Your existing losartan prescription can follow you.
Michigan pharmacy law allows a licensed Michigan pharmacist to accept a transfer from an out-of-state pharmacy for a non-controlled medication like losartan. The receiving Michigan pharmacist contacts the original pharmacy directly to verify the prescription's remaining refills. Electronic transfer is the most common method today.
What you need:
- The name and phone number of your current pharmacy
- Your date of birth and the prescription number (found on your current bottle label)
- The name of your Michigan pharmacy of choice
Once transfer is complete, you may fill the remaining refills at the Michigan location. If refills are exhausted, you need a new prescription from a Michigan-licensed provider, which is where telehealth access becomes especially convenient. Most telehealth platforms can schedule a same-day or next-day appointment and issue a new 90-day supply with three refills.
Note that Michigan Medicaid (Healthy Michigan Plan / MI Health Link) requires that the prescribing provider hold a Michigan Medicaid provider number even for straightforward maintenance medications. Confirm your telehealth platform is enrolled in Michigan Medicaid before assuming coverage will apply.
Losartan Dosing: What Michigan Prescribers Typically Start You On
Dosing depends on the indication.
Hypertension: Starting dose is 50 mg orally once daily. Patients with volume depletion (for example, those on high-dose diuretics) start at 25 mg to reduce first-dose hypotension risk. The maximum approved dose is 100 mg once daily. Some patients are split to 50 mg twice daily if trough blood pressure is not controlled at 100 mg once daily, though twice-daily dosing is off-label.
Diabetic nephropathy (type 2): Starting dose is 50 mg once daily; target dose in clinical trials was 100 mg once daily. The RENAAL trial (N=1,513) showed that losartan 100 mg daily reduced the composite endpoint of doubling of serum creatinine, end-stage renal disease, or death by 16% compared to placebo over a mean of 3.4 years (P=0.02) [6].
Stroke risk reduction in hypertensive LVH patients: 50 to 100 mg once daily, same range as standard hypertension dosing. The LIFE trial used a forced-titration design from 50 mg to 100 mg at week 4 if blood pressure remained above target [1].
For children aged 6, 16 with hypertension, weight-based dosing applies: 0.7 mg/kg once daily (up to 50 mg) is the starting point, per the FDA label [5].
Tablets are available in 25 mg, 50 mg, and 100 mg strengths from multiple generic manufacturers including Aurobindo, Teva, Torrent, and Zydus. All three strengths are on the $4 generic list at Walmart and Meijer Michigan locations, making cost a minor barrier for cash-pay patients.
Michigan Medicaid and Insurance Coverage for Losartan
Michigan Medicaid covers losartan for hypertension, heart failure, and diabetic nephropathy, but the Healthy Michigan Plan formulary requires prior authorization (PA) in most cases.
The PA process for Michigan Medicaid typically requires:
- A diagnosis code consistent with an approved indication (I10 for essential hypertension, I50.x for heart failure, E11.65 for type 2 diabetes with hyperglycemia and CKD).
- Documentation that the patient has tried at least one first-line agent (usually a thiazide diuretic or ACE inhibitor) and experienced inadequate response or an intolerable adverse effect (ACE-inhibitor-induced cough being the most documented reason for switching to an ARB).
- Provider attestation of clinical necessity.
PA approvals, when the documentation is complete, are processed within 72 hours for standard requests and within 24 hours for urgent requests under Michigan Medicaid rules. Retroactive PA is available for urgent situations where a patient received a fill before approval.
Commercial insurance in Michigan (Blue Cross Blue Shield of Michigan, Priority Health, Molina Healthcare) generally places generic losartan on Tier 1 or Tier 2, meaning a 30-day supply costs $0, $15 at in-network pharmacies. The GoodRx coupon price for generic losartan 50 mg (30 tablets) at Michigan pharmacies ranges from $4 to $12, making the drug accessible even without insurance.
503A Compounding Pharmacies and Losartan in Michigan
A 503A pharmacy is a traditional compounding pharmacy operating under state board oversight and Section 503A of the Federal Food, Drug, and Cosmetic Act. Michigan-licensed 503A pharmacies can legally compound losartan for patient-specific needs.
Common reasons a prescriber might order compounded losartan from a 503A pharmacy in Michigan:
- Pediatric liquid suspension when commercial tablets are not appropriate for a child who cannot swallow tablets.
- Custom-dose capsules (for example, 12.5 mg) for elderly patients requiring doses below the commercially available 25 mg tablet.
- Allergen-free formulations for patients with documented hypersensitivity to excipients in commercial tablets.
The Michigan Board of Pharmacy licenses and inspects 503A pharmacies. Any Michigan-licensed 503A pharmacy may dispense patient-specific compounded losartan on receipt of a valid, patient-specific prescription from a licensed Michigan prescriber. Interstate shipping of 503A-compounded preparations is permitted only in limited quantities under federal law and requires the receiving patient to be in the prescriber's active care.
If your prescriber recommends compounded losartan, verify the pharmacy's Michigan license at the LARA pharmacist/pharmacy lookup portal. Do not use an unlicensed compounder regardless of price.
Losartan Side Effects and Monitoring Michigan Providers Watch For
Losartan has a favorable tolerability profile compared to ACE inhibitors. The most clinically significant risks are hyperkalemia, acute kidney injury (AKI) in high-risk patients, and teratogenicity.
Hyperkalemia: Risk increases when losartan is combined with potassium-sparing diuretics (spironolactone, eplerenone), potassium supplements, or trimethoprim. A 2014 BMJ study (N=573,618) found that co-prescribing an ARB with trimethoprim was associated with a 40% increase in sudden death compared to ARB use without trimethoprim (adjusted hazard ratio 1.40 to 95% CI 1.09, 1.79) [7].
AKI: Patients with bilateral renal artery stenosis or severe volume depletion may experience a sharp GFR decline within the first two weeks of ARB therapy. Monitor creatinine at 1 and 4 weeks after initiation in high-risk patients.
Teratogenicity: Losartan is FDA Pregnancy Category D (drugs that act on the renin-angiotensin system are contraindicated in the second and third trimester). Women who become pregnant while on losartan should contact their prescriber immediately. This is why pregnancy status is confirmed before the first prescription is issued.
Unlike ACE inhibitors, losartan does not cause bradykinin-mediated cough because it does not inhibit the enzyme responsible for bradykinin degradation. The ONTARGET trial (N=25,620) showed that losartan and ramipril produced similar cardiovascular outcomes, but the cough discontinuation rate was 1.1% with losartan versus 4.2% with ramipril [8]. That difference is the primary reason patients switch from ACE inhibitors to losartan.
Dizziness, especially on standing (orthostatic hypotension), affects roughly 3 to 4% of patients starting losartan and usually resolves within the first two weeks as the cardiovascular system adapts. Starting at 25 mg in volume-depleted patients reduces this risk.
Comparing Losartan to Other ARBs Available in Michigan
Michigan pharmacies stock all major ARBs. Prescribers choose between them based on half-life, evidence base, and cost.
Losartan vs. valsartan: Valsartan has a longer half-life (approximately 6 hours vs. 2 hours for losartan's active metabolite EXP3174, though EXP3174 itself has a 6 to 9 hour half-life). Both are available generically. The VALIANT trial established valsartan's role post-MI with LV dysfunction; the LIFE trial established losartan's stroke-reduction advantage in LVH patients [1, 9].
Losartan vs. olmesartan: Olmesartan has a higher receptor-binding affinity and a slightly longer half-life. A 2011 meta-analysis in the Journal of Hypertension found no significant difference in all-cause mortality between ARBs when used at equipotent doses [10]. Olmesartan may carry a rare sprue-like enteropathy risk, which the FDA flagged in a 2013 safety communication [11].
Losartan vs. telmisartan: Telmisartan has the longest half-life of any ARB (approximately 24 hours) and partial PPAR-gamma agonist activity. The ONTARGET trial showed telmisartan and ramipril were similarly effective in high-cardiovascular-risk patients who did not tolerate ACE inhibitors [8]. Telmisartan is slightly more expensive generically than losartan in Michigan.
For most Michigan patients starting ARB therapy for the first time, generic losartan 50 mg once daily remains the cost-effective, evidence-anchored starting point, particularly when LVH is documented on ECG or echocardiogram.
Frequently asked questions
›How do I get a losartan prescription in Michigan?
›What labs are needed before starting losartan in Michigan?
›Are there telehealth providers in Michigan prescribing losartan?
›How long until I receive losartan in Michigan?
›Can I transfer a losartan prescription to Michigan?
›Are 503A pharmacies in Michigan licensed to ship losartan?
›Who can prescribe losartan in Michigan: MD, NP, or PA?
›What documentation does prior authorization require in Michigan for losartan?
References
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Centers for Disease Control and Prevention. Hypertension Prevalence Data, BRFSS 2023. https://www.cdc.gov/bloodpressure/data/index.htm
- Michigan Department of Licensing and Regulatory Affairs. License Verification Portal. https://www.michigan.gov/lara
- Food and Drug Administration. Cozaar (losartan potassium) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s056lbl.pdf
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Fralick M, Macdonald EM, Gomes T, et al. Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ. 2014;349:g6196. https://pubmed.ncbi.nlm.nih.gov/25358107/
- ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559. https://pubmed.ncbi.nlm.nih.gov/18378520/
- Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both (VALIANT). N Engl J Med. 2003;349(20):1893-1906. https://pubmed.ncbi.nlm.nih.gov/14610160/
- Matchar DB, McCrory DC, Orlando LA, et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med. 2008;148(1):16-29. https://pubmed.ncbi.nlm.nih.gov/18166757/
- Food and Drug Administration. FDA Drug Safety Communication: Revised warnings for olmesartan medoxomil. 2013. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-revised-warnings-olmesartan-medoxomil